Applicant, as named in the Orange Book

Pacira Pharms Inc

Pacira BioSciences Inc · Nasdaq: PCRX

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Zilretta on 4 Aug 2031. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Zilretta NDA 208845 triamcinolone acetonide	triamcinolone acetonide	4 Aug 2031 patent	patent
Exparel NDA 022496 · 2 strengths bupivacaine	bupivacaine	2 Jul 2044 patent	patent

Exparel · Exclusivity expires within 90 days I-929Exclusivity expires 9 Nov 2026Detected 24 Oct 2026
Exparel · Exclusivity expires within 90 days I-929Exclusivity expires 9 Nov 2026Detected 24 Oct 2026